Use of TpCO2 (Transcutaneous CO2 Measurement)as PaCO2 Predictor During Non Invasive Ventilation (NIV) in Case of Acute Hypercapnic Respiratory Failure

University of Lausanne Hospitals1 site in 1 country20 target enrollmentFebruary 2013

ConditionsHypercapnic Respiratory Failure

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Hypercapnic Respiratory Failure
Sponsor: University of Lausanne Hospitals
Enrollment: 20
Locations: 1
Primary Endpoint: Comparison between TpCO2 (transcutaneous non invasive CO2 partial pressure measurement) and PaCO2 (obtained by blood gas analysis) values during NIV treatment.
Status: Completed
Last Updated: 10 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

In patients suffering from hypercapnic respiratory failure and treated by non invasive ventilation (NIV), the interest of using transcutaneous CO2 measurement to evaluate PaCO2 and PaCO2 variation over time is unknown and will be evaluated in this study. Measurements will be done during one-hour NIV treatments.

Registry

clinicaltrials.gov

Start Date

February 2013

End Date

March 2015

Last Updated

10 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

University of Lausanne Hospitals

Responsible Party

Principal Investigator

Prof. Philippe Jolliet

Principal investigator

University of Lausanne Hospitals

Eligibility Criteria

Inclusion Criteria

•ICU patient equipped with an arterial line
•NIV treatment prescribed by the clinician in charge
•Hypercapnia defined by PaCO2\> 42mmHg

Exclusion Criteria

•Severe hemodynamic instability
•Severe psychiatric disorders
•Denied consent
•Age \< 18 years

Outcomes

Primary Outcomes

Comparison between TpCO2 (transcutaneous non invasive CO2 partial pressure measurement) and PaCO2 (obtained by blood gas analysis) values during NIV treatment.

Time Frame: sixty minutes